Cargando…

Evaluation of Planned Subgroup Analysis in Protocols of Randomized Clinical Trials

This cross-sectional study compares randomized clinical trial protocols to assess the prevalence and reporting quality of planned subgroup analyses over time.

Detalles Bibliográficos
Autores principales:	Taji Heravi, Ala, Gryaznov, Dmitry, Schandelmaier, Stefan, Kasenda, Benjamin, Briel, Matthias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552052/ https://www.ncbi.nlm.nih.gov/pubmed/34705015 http://dx.doi.org/10.1001/jamanetworkopen.2021.31503

Ejemplares similares

Resource use, costs, and approval times for planning and preparing a randomized clinical trial before and after the implementation of the new Swiss human research legislation
por: Speich, Benjamin, et al.
Publicado: (2019)

Characteristics and interpretation of subgroup analyses based on tumour characteristics in randomised trials testing target-specific anticancer drugs: design of a systematic survey
por: Schandelmaier, Stefan, et al.
Publicado: (2020)

Premature Discontinuation of Prospective Clinical Studies Approved by a Research Ethics Committee – A Comparison of Randomised and Non-Randomised Studies
por: Blümle, Anette, et al.
Publicado: (2016)

Rationale and design of repeated cross-sectional studies to evaluate the reporting quality of trial protocols: the Adherence to SPIrit REcommendations (ASPIRE) study and associated projects
por: Gryaznov, Dmitry, et al.
Publicado: (2020)

Reliability of Trial Information Across Registries for Trials With Multiple Registrations: A Systematic Review
por: Speich, Benjamin, et al.
Publicado: (2021)

Reporting quality of clinical trial protocols: a repeated cross-sectional study about the Adherence to SPIrit Recommendations in Switzerland, CAnada and GErmany (ASPIRE-SCAGE)
por: Gryaznov, Dmitry, et al.
Publicado: (2022)

Investigational medicinal products, related costs and hospital pharmacy services for investigator-initiated trials: A mixed-methods study
por: Taji Heravi, Ala, et al.
Publicado: (2022)

Scoping review and characteristics of publicly available checklists for assessing clinical trial feasibility
por: Gloy, Viktoria, et al.
Publicado: (2022)

Towards full clinical trial registration and results publication: longitudinal meta-research study in Northwestern and Central Switzerland
por: Klatte, Katharina, et al.
Publicado: (2023)

Nonregistration, discontinuation, and nonpublication of randomized trials: A repeated metaresearch analysis
por: Speich, Benjamin, et al.
Publicado: (2022)

Subgroup analyses in randomised controlled trials: cohort study on trial protocols and journal publications
por: Kasenda, Benjamin, et al.
Publicado: (2014)

Investigation of continuous effect modifiers in a meta-analysis on higher versus lower PEEP in patients requiring mechanical ventilation - protocol of the ICEM study
por: Kasenda, Benjamin, et al.
Publicado: (2014)

Reporting Quality of Journal Abstracts for Surgical Randomized Controlled Trials Before and After the Implementation of the CONSORT Extension for Abstracts
por: Speich, Benjamin, et al.
Publicado: (2019)

Exploring reasons for recruitment failure in clinical trials: a qualitative study with clinical trial stakeholders in Switzerland, Germany, and Canada
por: Briel, Matthias, et al.
Publicado: (2021)

A longitudinal assessment of trial protocols approved by research ethics committees: The Adherance to SPIrit REcommendations in the UK (ASPIRE-UK) study
por: Speich, Benjamin, et al.
Publicado: (2022)

Prediction of RECRUITment In randomized clinical Trials (RECRUIT-IT)—rationale and design for an international collaborative study
por: Kasenda, Benjamin, et al.
Publicado: (2020)

Subgroup Analysis of Trials Is Rarely Easy (SATIRE): a study protocol for a systematic review to characterize the analysis, reporting, and claim of subgroup effects in randomized trials
por: Sun, Xin, et al.
Publicado: (2009)

Agreements between Industry and Academia on Publication Rights: A Retrospective Study of Protocols and Publications of Randomized Clinical Trials
por: Kasenda, Benjamin, et al.
Publicado: (2016)

Discontinuation and non-publication of randomised clinical trials supported by the main public funding body in Switzerland: a retrospective cohort study
por: Amstutz, Alain, et al.
Publicado: (2017)

Association of Supporting Trial Evidence and Reimbursement for Off-Label Use of Cancer Drugs
por: Herbrand, Amanda Katherina, et al.
Publicado: (2021)

Concerns about subgroup analyses and reason for stopping remdesivir trial
por: Vijayaraghavan, Bharath Kumar Tirupakuzhi
Publicado: (2022)

Planning and comparisons in clinical trials.
por: Kay, H. E.
Publicado: (1983)

A systematic survey of randomised trials that stopped early for reasons of futility
por: Walter, S. D., et al.
Publicado: (2020)

Initiation and continuation of randomized trials after the publication of a trial stopped early for benefit asking the same study question: STOPIT-3 study design
por: Prutsky, Gabriela J, et al.
Publicado: (2013)

Comparison of randomized controlled trials discontinued or revised for poor recruitment and completed trials with the same research question: a matched qualitative study
por: Briel, Matthias, et al.
Publicado: (2019)

Public access to protocols of contemporary cancer randomized clinical trials
por: Babu, Christopher, et al.
Publicado: (2021)

The authors respond to “Concerns about subgroup analyses and reason for stopping remdesivir trial”
por: Murthy, Srinivas
Publicado: (2022)

Learning from failure - rationale and design for a study about discontinuation of randomized trials (DISCO study)
por: Kasenda, Benjamin, et al.
Publicado: (2012)

Comment on: ‘Subgroup effects in a randomized trial of different types and doses of exercise during breast cancer chemotherapy'
por: Beijers, A J M, et al.
Publicado: (2015)

Digital tools for trial recruitment and retention—plenty of tools but rigorous evaluation is in short supply
por: Treweek, Shaun, et al.
Publicado: (2020)

Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials
por: Amstutz, Alain, et al.
Publicado: (2023)

“C‐reactive protein levels and risk of dementia”: Subgroup analyses in Mendelian randomization are likely to be misleading
por: Burgess, Stephen
Publicado: (2022)

Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2: Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2)
por: Griessbach, Alexandra, et al.
Publicado: (2023)

Problems of subgroup analysis in randomized controlled trial
por: Priebe, Hans-Joachim
Publicado: (2020)

Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial
por: Soto, Alonso, et al.
Publicado: (2021)

Towards the development of a comprehensive framework: Qualitative systematic survey of definitions of clinical research quality
por: von Niederhäusern, Belinda, et al.
Publicado: (2017)

Beware of subgroup analysis
por: Mitsnefes, Mark M., et al.
Publicado: (2008)

The reporting of studies using routinely collected health data was often insufficient
por: Hemkens, Lars G., et al.
Publicado: (2016)

Evaluation of Lymphocyte Subgroups in Children with Glucose-6-Phosphate Dehydrogenase Deficiency
por: Orhan, Mehmet Fatih, et al.
Publicado: (2023)

Evaluating the efficacy of an Advanced Care Planning Program for Health Decisions in patients with advanced heart failure: protocol for a Randomized Clinical Trial
por: Sánchez, Beatriz, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k4e3nha49cb2jcb8764qhft83p